|
| Clavulanate Potassium with Silicon Dioxide (Syloid) |
 |
|
 |
| |
| |
Characteristics:
A blended powder mixture of Clavulanate potassium and silicon dioxide
Weight Ratio 1:1
Application:
The product is suitable for the manufacture of powder for deferral following the accumulation of proper Excipients and Amoxicillin.
Therapeutic category:
A beta- lactamase inhibitor that augments the activity of amoxicillin as a wide-ranging antibiotic
Pharmacopoeia Quality:
The Clavulanate potassium conforms to the
- USP
- Ph.Eur.
- BP
latest editions
Appearance:
White to off-white crystalline powder
Content (HPLC):
K-Clavulanate: 46.1 - 52.8%
(clavulanic acid): (38.7 - 44. 3%)
Water (Karl Fischer): < 1.5 %
Tapped bulk density (U SP): > 0.25 g/ml
Shelf life:
3 years in the original packaging beneath 'storage conditions
Storage conditions:
Less than 15 °C, protected from light and moisture
Packaging:
See segment "Packaging"
Regulatory Information:
See segment "Regulatory Information"
|
| The information contained herein is believed to be accurate but all recommendations are made without warranty and nothing be construed to imply any guarantee. |
|
| |
|
|
|
|
